Cancers bronchiques localement avancés: le rôle du chirurgien

Reck, 2013, Management of non-small-cell lung cancer: recent developments, Lancet, 382, 709, 10.1016/S0140-6736(13)61502-0 Goldstraw, 2016, The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer, J Thorac Oncol, 11, 39, 10.1016/j.jtho.2015.09.009 Rami-Porta, 2015, The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer, J Thorac Oncol, 10, 990, 10.1097/JTO.0000000000000559 Rami-Porta, 2005, Complete resection in lung cancer surgery: proposed definition, Lung Cancer, 49, 25, 10.1016/j.lungcan.2005.01.001 Graham, 1999, Systematic nodal dissection in the intrathoracic staging of patients with non-small cell lung cancer, J Thorac Cardiovasc Surg, 117, 246, 10.1016/S0022-5223(99)70419-8 Rice, 2002, Radical resections for T4 lung cancer, The Surgical clinics of North America, 82, 573, 10.1016/S0039-6109(02)00017-8 Van Schil, 2011, Current surgical treatment of non-small-cell lung cancer, Expert Rev Anticancer Ther, 11, 1577, 10.1586/era.11.142 Garrido, 2007, Long-term survival associated with complete resection after induction chemotherapy in stage IIIA (N2) and IIIB (T4N0-1) non small-cell lung cancer patients: the Spanish Lung Cancer Group Trial 9901, J Clin Oncol, 25, 4736, 10.1200/JCO.2007.12.0014 Van Schil, 2009, Surgical treatment of stage III non-small cell lung cancer, Eur J Cancer, 45, 106, 10.1016/S0959-8049(09)70022-X Van Schil, 2016, Stage IIIA-N2 non-small-cell lung cancer: from ‘surprise’ involvement to surgical nightmare, Eur J Cardiothorac Surg, 49, 1613, 10.1093/ejcts/ezv457 Eberhardt, 2015, 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer, Ann Oncol, 26, 1573, 10.1093/annonc/mdv187 Van Schil, 2017, Surgical Management of Stage IIIA Non-Small Cell Lung Cancer, Frontiers in oncology, 7, 249, 10.3389/fonc.2017.00249 Le Pechoux, 2015, Postoperative Radiotherapy for Pathologic N2 Non-Small-Cell Lung Cancer Treated With Adjuvant Chemotherapy: Need for Randomized Evidence, J Clin Oncol, 33, 2930, 10.1200/JCO.2015.62.1458 Albain, 2009, Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial, Lancet, 374, 379, 10.1016/S0140-6736(09)60737-6 van Meerbeeck, 2007, Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer, J Natl Cancer Inst, 99, 442, 10.1093/jnci/djk093 Van Schil, 2005, Morbidity and mortality in the surgery arm of EORTC 08941 trial, Eur Respir J, 26, 192, 10.1183/09031936.05.00127204 Eberhardt, 2015, Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE), J Clin Oncol, 33, 4194, 10.1200/JCO.2015.62.6812 Pless, 2015, Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial, Lancet, 386, 1049, 10.1016/S0140-6736(15)60294-X McElnay, 2015, Outcome of surgery versus radiotherapy after induction treatment in patients with N2 disease: systematic review and meta-analysis of randomised trials, Thorax, 70, 764, 10.1136/thoraxjnl-2014-206292 Zhao, 2019, The Optimal Treatment for Stage IIIA-N2 Non-small-cell Lung Cancer: A Network Meta-analysis, Ann Thorac Surg, 107, 1866, 10.1016/j.athoracsur.2018.11.024 Postmus, 2017, Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, 28, iv1, 10.1093/annonc/mdx222 Detterbeck, 2013, Executive Summary: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines, Chest, 143, 7S, 10.1378/chest.12-2377 Antonia, 2018, Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC, N Engl J Med, 379, 2342, 10.1056/NEJMoa1809697 Forde, 2018, Neoadjuvant PD-1 Blockade in Resectable Lung Cancer, N Engl J Med, 378, 1976, 10.1056/NEJMoa1716078 Van Breussegem, 2017, Salvage surgery after high-dose radiotherapy, Journal of thoracic disease, 9, S193, 10.21037/jtd.2017.03.88 Casiraghi, 2017, Salvage Surgery After Definitive Chemoradiotherapy for Non-small Cell Lung Cancer, Semin Thorac Cardiovasc Surg, 29, 233, 10.1053/j.semtcvs.2017.02.001